110 HR 1237 RH: Cytology Proficiency Improvement Act of 2008 U.S. House of Representatives 2008-04-08 text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.

Union Calendar No. 348 110th CONGRESS 2d Session

H. R. 1237

[Report No. 110–566]

IN THE HOUSE OF REPRESENTATIVES

February 28, 2007

Mr. Gordon of Tennessee (for himself, Mr. Price of Georgia, Ms. Foxx, Ms. Herseth, and Mr. Deal of Georgia) introduced the following bill; which was referred to the Committee on Energy and Commerce

April 8, 2008

Additional sponsors: Mr. Rogers of Michigan, Mr. Burgess, Mr. Cohen, Mr. English of Pennsylvania, Mr. Jefferson, Mr. Boucher, Mrs. Myrick, Mr. Gene Green of Texas, Mr. Holden, Ms. Hooley, Mr. Burton of Indiana, Mr. Shuster, Mr. Hinojosa, Mr. McNulty, Mr. Shimkus, Mr. Weldon of Florida, Mr. Boustany, Mr. Gonzalez, Mr. Boswell, Mr. Sullivan, Ms. Baldwin, Mr. Doyle, Mr. Latham, Mr. Ryan of Wisconsin, Mr. Bonner, Mr. Neal of Massachusetts, Mrs. Cubin, Mr. Coble, Mr. Paul, Mr. Tim Murphy of Pennsylvania, Mr. Pitts, Mr. Young of Alaska, Mr. David Davis of Tennessee, Mrs. Maloney of New York, Mr. Rothman, Mr. Sires, Mr. Gingrey, Mrs. McCarthy of New York, Mr. Pickering, Mr. Wynn, Mr. McGovern, Ms. Roybal-Allard, Mr. Weiner, Mrs. Blackburn, Mr. Snyder, Ms. DeGette, Mr. Moran of Virginia, Ms. Eshoo, Mr. Butterfield, Mrs. Capps, Mr. Carnahan, Mr. Hare, Mrs. Bono Mack, Mr. Renzi, Mr. Abercrombie, Mr. Platts, Mr. Allen, Mr. Hill, Mr. Ross, Ms. Harman, Mr. Buyer, Mr. Ramstad, Ms. Woolsey, Mr. Donnelly, Mr. Kildee, Mr. Hall of Texas, Mr. Higgins, Mr. Lincoln Diaz-Balart of Florida, Ms. Slaughter, Mr. Baird, Mr. Ferguson, Mrs. Wilson of New Mexico, Mr. Manzullo, Mr. Braley of Iowa, Mr. Engel, Mr. Berry, Mr. Boozman, Mr. Wolf, Mr. Payne, Mr. Fortuño, Mr. Davis of Illinois, Mr. Terry, Mr. Kind, Mr. Melancon, Mrs. Jo Ann Davis of Virginia, Mr. Nadler, Mr. Herger, Mr. Kagen, Mr. Reynolds, Mr. Altmire, Mr. Hinchey, Mr. Kennedy, Mr. Levin, Ms. Schakowsky, Mr. Radanovich, Mr. Bilirakis, Mr. Fossella, Mr. Markey, Mr. Lewis of Georgia, Mr. Tiberi, Mr. Barrow, Mr. Pascrell, Mr. Castle, Mr. Upton, Ms. Solis, Mr. Issa, Ms. Kaptur, Mr. Hall of New York, Mr. Whitfield of Kentucky, Mr. Meek of Florida, Mr. Langevin, Mr. Inslee, Mr. Waxman, Mr. Matheson, Mr. Thompson of Mississippi, Mr. Sensenbrenner, Mr. King of New York, Mr. Courtney, Ms. Berkley, Mr. Petri, Mr. Larson of Connecticut, Mr. Scott of Georgia, Ms. Schwartz, Mr. Kirk, Mr. Udall of New Mexico, Mr. Towns, Mr. Camp of Michigan, Mrs. Boyda of Kansas, Mr. Stupak, Ms. Ginny Brown-Waite of Florida, Mr. Berman, Ms. Zoe Lofgren of California, Mr. Walden of Oregon, Mr. Bishop of Georgia, Mr. Johnson of Illinois, Mr. Costello, Mr. Calvert, Ms. Richardson, Mr. Stearns, Mr. Olver, Mr. Walsh of New York, Mr. Al Green of Texas, Mrs. Gillibrand, Mr. LoBiondo, Mr. Kuhl of New York, Mr. Brady of Pennsylvania, Mr. McIntyre, Mr. Welch of Vermont, Mr. Shadegg, Mr. Buchanan, Mrs. Christensen, Mr. Dent, Ms. Sutton, Mrs. Jones of Ohio, Mr. Shays, Mr. Fattah, Ms. Moore of Wisconsin, Ms. DeLauro, Mr. Porter, Mr. Murphy of Connecticut, Mr. Sam Johnson of Texas, Ms. Clarke, Mr. Lynch, Mr. Rush, Mr. LaTourette, Mr. Ehlers, Ms. Tsongas, Mr. Hoekstra, Mr. Boren, Mr. Feeney, and Ms. Shea-Porter

April 8, 2008

Reported with an amendment, committed to the Committee of the Whole House on the State of the Union, and ordered to be printed

Strike out all after the enacting clause and insert the part printed in italic

A BILL

To amend the Public Health Service Act to provide revised standards for quality assurance in screening and evaluation of gynecologic cytology preparations, and for other purposes.

Short title

This Act may be cited as the

Cytology Proficiency Improvement Act of 2007

Revised standards for quality assurance in screening and evaluation of gynecologic cytology preparations

(a)

In general

Section 353(f)(4)(B)(iv) of the Public Health Service Act (42 U.S.C. 263a(f)(4)(B)(iv)) is amended to read as follows:

(b)

Effective date and implementation; termination of current program of individual proficiency testing

(1)

Effective date and implementation

Except as provided in paragraph (2), the amendment made by subsection (a) applies to gynecologic cytology services provided on or after the date that is one year after the date of the enactment of this Act, and the Secretary of Health and Human Services (hereafter in this subsection referred to as the Secretary) shall issue final regulations implementing such amendment not later than 270 days after such date of enactment. (2)

Termination of current individual proficiency testing program

As of the date of the enactment of this Act, the Secretary shall terminate the individual proficiency testing program established pursuant to section 353(f)(4)(B)(iv) of the Public Health Service Act (42 U.S.C. 263a(f)(4)(B)(iv)), as in effect before the enactment of this section.

Short title

This Act may be cited as the

Cytology Proficiency Improvement Act of 2008

Revised standards for quality assurance in screening and evaluation of gynecologic cytology preparations

(a)

In general

Section 353(f)(4)(B)(iv) of the Public Health Service Act (42 U.S.C. 263a(f)(4)(B)(iv)) is amended to read as follows:

(iv)requirements that each clinical laboratory— (I)ensure that all individuals involved in screening and interpreting cytological preparations at the laboratory participate annually in a continuing medical education program in gynecologic cytology that— (aa)is approved by the Accrediting Council for Continuing Medical Education or the American Academy of Continuing Medical Education; and (bb)provides each individual participating in the program with gynecologic cytological preparations (in the form of referenced glass slides or equivalent technologies) designed to improve the locator, recognition, and interpretive skills of the individual; (II)maintain a record of the cytology continuing medical education program results for each individual involved in screening and interpreting cytological preparations at the laboratory; (III)provide that the laboratory director shall take into account such results and other performance metrics in reviewing the performance of individuals involved in screening and interpreting cytological preparations at the laboratory and, when necessary, identify needs for remedial training or a corrective action plan to improve skills; and (IV)submit the continuing education program results for each individual and, if appropriate, plans for corrective action or remedial training in a timely manner to the laboratory’s accrediting organization for purposes of review and on-going monitoring by the accrediting organization, including reviews of the continuing medical education program results during on-site inspections of the laboratory.

(b)

Effective date and implementation; termination of current program of individual proficiency testing

(1)

Effective date and implementation

Except as provided in paragraph (2), the amendment made by subsection (a) applies to gynecologic cytology services provided on or after the first day of the first calendar year beginning 1 year or more after the date of the enactment of this Act, and the Secretary of Health and Human Services (hereafter in this subsection referred to as the Secretary) shall issue final regulations implementing such amendment not later than 270 days after such date of enactment. (2)

Termination of current individual testing program

The Secretary of Health and Human Services shall terminate the individual proficiency testing program established pursuant to section 353(f)(4)(B)(iv) of the Public Health Service Act (42 U.S.C. 263a(f)(4)(B)(iv)), as in effect on the day before the date of the enactment of subsection (a), at the end of the calendar year which includes the date of enactment of the amendment made by subsection (a).

April 8, 2008

Reported with an amendment, committed to the Committee of the Whole House on the State of the Union, and ordered to be printed